Bench International > blog new (Page 3)

Advances in Alzheimer’s Disease

By Gail Rosenblum - Advances are being made globally in the area of Alzheimer’s disease and related dementia disorders, and Bench International has been privileged to work extensively in this field, partnering most recently with Chase Pharmaceuticals, Axovant Sciences and Bionomics Limited. Designated in 1983 by...

Another Hindrance to Gene Therapy?

By Tim Silcott - Gene Therapy has been a top topic in life science for discussion in the past few years, with many companies delving into the area. Now that the field is maturing, we are seeing some setbacks from some of the top entrants...

“Value vs. Value”

By DeeDee DeMan - This article begins to represent a definitive difference between "Value" vs. "Value". It's easy to identify the investment "value" in this current M&A flurry. It is less transparent to understand the "value" of how R&D innovation translates as we focus on...

The Art of Courage in Controversy

By DeeDee DeMan - Whether you agree with him or not, Scott Gottlieb, MD, is a voice of definitive courage in a time where we are all watching "ducking and covering." Bench is honored and proud to have had the opportunity of taking Scott out...